Data fusion of fourier transform infrared spectra and powder x-ray diffraction patterns for pharmaceutical mixtures
Contents lists available at
Journal of Pharmaceutical and Biomedical Analysis
Data fusion of Fourier transform infrared spectra and powder X-ray diffraction
patterns for pharmaceutical mixtures
Rahul V. Haware , Patrick R. Wright , Kenneth R. Morris , Mazen L. Hamad
a University of Hawaii at Hilo, College of Pharmacy, 34 Rainbow Drive, Hilo, HI 96720, USA
b Department of Chemistry, University of Hawaii at Hilo, 200 W Kawili St., Hilo, HI 96720, USA
Fusing complex data from two disparate sources has been demonstrated to improve the accuracy in quan-
Received 18 May 2011
tifying active ingredients in mixtures of pharmaceutical powders. A four-component simplex-centroid
Received in revised form 9 August 2011
design was used to prepare blended powder mixtures of acetaminophen, caffeine, aspirin and ibuprofen.
Accepted 10 August 2011
The blends were analyzed by Fourier transform infra-red spectroscopy (FTIR) and powder X-ray diffrac-
Available online 17 August 2011
tion (PXRD). The FTIR and PXRD data were preprocessed and combined using two different data fusion
methods: fusion of preprocessed data (FPD) and fusion of principal component scores (FPCS). A partial
least square (PLS) model built on the FPD did not improve the root mean square error of prediction.
However, a PLS model built on the FPCS yielded better accuracy prediction than PLS models built on indi-
Multivariate analysis
Pharmaceutical powder mixtures
vidual FTIR and PXRD data sets. The improvement in prediction accuracy of the FPCS may be attributed to
Fourier transform infrared spectroscopy
the removal of noise and data reduction associated with using PCA as a preprocessing tool. The present
Powder X-ray diffraction
approach demonstrates the usefulness of data fusion for the information management of large data sets
from disparate sources.
2011 Elsevier B.V. All rights reserved.
A second obstacle associated with using high data density tools
arises when these techniques are used to make measurements on
The need to understand the critical material and process
samples that are considered non-ideal. An example of a non-ideal
attributes on the end product quality of pharmaceutical products
sample for FTIR is a heterogeneous, multi-component, solid state
is now an imperative with respect to the ICH Q8 guideline issued
pharmaceutical mixture. Ideally, the absorbance of infrared light
by FDA Consequently, quantitative and qualitative applica-
at a particular wavenumber will be directly proportional to the
tions of sophisticated high data density analytical tools like Fourier
concentration of each absorbing species; however, the variation
transform infrared spectroscopy (FTIR), powder X-ray diffrac-
in the extent of light scattering at particulate interfaces tends to
tion (PXRD), Raman spectroscopy and near infrared spectroscopy
significantly increase the error in the measurement. This artefact,
have gained wider acceptance in characterizing pharmaceutical
caused by variation in the physical aspects of the sample matrix,
processes, intermediates and products major obstacle asso-
may prevent the use of FTIR as a technique for the quantitative
ciated with these analytical techniques is the generation of large
characterization of multi-component solid state pharmaceutical
data matrices which may be complex and difficult to interpret.
Thus, it is critical that the end users of these tools have appropriate
PXRD, on the other hand, is a technique known for structural
methods of data reconciliation in order to extract the sought after
characterization, not chemical characterization, of single compo-
information for subsequent prediction of the process outcomes.
nent solid-state material samples. Thus, neither method is ideal
Multivariate analysis, also called chemometrics when applied to
for the quantitative chemical characterization of multi-component,
chemical-specific applications, has been offered as one key to
pharmaceutical samples. However, since the two techniques yield
extracting critical information from large data sets generated by
different kinds of information, their individual data sets can be com-
a single high data density tool.
bined into a single data set which provides more information than
either technique by itself. What is not clear is how data from the
two techniques can be combined to better perform a single task
than either technique could perform on its own.
An important technique emerging from the informatics domain
Corresponding author. Tel.: +1 808 933 2194; fax: +1 808 974 7693.
is data fusion. The aim of data fusion is to facilitate the faultless
E-mail address: (M.L. Hamad).
1 Student undertaking summer internship from Albert-Ludwigs-University
integration of information from various sources to develop a single
Freiburg, Freiburg, Germany.
model or decision is hypothesized that data fusion may be a
0731-7085/$ – see front matter
2011 Elsevier B.V. All rights reserved.
R.V. Haware et al. / Journal of Pharmaceutical and Biomedical Analysis 56 (2011) 944–949
equal proportions of the selected two components, 3 face centers
Four component simplex-centroid experimental design in units of percentage con-
of the ternary mixtures with equal proportions of the selected three
centration [acetaminophen (APAP), caffeine (CAF), ibuprofen (IBU) and aspirin
components, 4 axes of the quaternary mixtures with varying pro-
portions of the selected four components and 3 center experiments
of the quaternary mixtures with equal proportions of the selected
four components to check both the linearity and repeatability of
the experimental results.
2.3. Fourier transform infrared spectroscopy (FTIR)
The spectra of the 21 calibration samples and 4 unknown
samples were collected using a Thermo Nicolet NEXUS 670 FTIR
instrument equipped with a Nicolet Smart MIRacle accessory
(Thermo Fisher Scientific, Waltham, MA). The MIRacle accessory
uses a glassy material known as AMTIR (Amorphous Material Trans-
mitting Infrared Radiation – composed of Ge, As, and Se) to measure
the absorbance in the attenuated total reflectance (ATR) mode.
The samples were measured by inserting approximately 25 mg of
mixed sample powder into the trough insert and supplying suffi-
cient pressure using the micrometer pressure clamp to compress
the sample against the AMTIR glass. For each sample, 32 scans in the
wavenumber range from 650 cm−1 to 4000 cm−1 (at a resolution of
4 cm−1) were averaged to produce a single spectrum. The resulting
spectral data vectors contained 1738 data points. The spectral data
useful strategy to integrate data from FTIR and PXRD for the char-
were acquired in absorbance mode using OMNIC software (Thermo
acterization of multi-component, pharmaceutical samples. Various
Fisher Scientific, Waltham, MA) and exported to MATLAB® (Math-
scientific and engineering disciplines, such as robotics, remote
works, Natick, MA) and the Unscrambler® (Unscrambler® 10.0.1,
sensing, image analysis, and analytical chemistry, are employing
CAMO AS, Norway) for data processing.
data fusion concepts and realizing better information management
data fusion coupled with multivariate analysis
(MVA) is a new and potentially very powerful approach to modeling
2.4. Powder X-ray diffraction (PXRD)
The goal of the present work was to investigate the suitability of
The PXRD data were collected for all experiments that were
data fusion combination with MVA methods to build more
conducted on a Bruker D8 Advanced system in Bragg-Brentano
accurate predictive models. Principal component analysis (PCA)
geometry using a Cu K␣ radiation point source ( = 1.5406 ˚A) at
was used for exploratory data analysis and it was also used as a data
an operating voltage and amperage of 40.0 kV and 40.0 mA, respec-
reduction technique prior to data fusion. Partial least square (PLS)
tively. The powdered samples were analyzed in a low background
regression was ultimately used to build predictive models based on
cell. The samples (approx. 25 mg) were scanned at a rate of 0.005◦
the FTIR data set, the PXRD data set, the data set prepared by fusion
per minute at step size of 0.01◦ from 5◦ to 35◦ 2, resulting in row
of preprocessed data (FPD) and the data set prepared by fusion
vectors of 2894 data points for each sample. The obtained PXRD
of principal component scores (FPCS). The quantitative prediction
data was exported to Unscrambler® prior to MVA modeling and
accuracy of fractions of acetylsalicylic acid, caffeine, ibuprofen, and
data fusion.
acetaminophen in blended powder samples was compared using
leave-one-out cross validation. The models were also used to pre-
dict fractions of the four components in blind, unknown powder
The data from FTIR and PXRD were combined using two differ-
ent fusion methods: fusion of preprocessed data (FPD) and fusion
2. Experimental and methods
of principal component scores (FPCS). It was necessary to prepro-
cess each set of data individually prior to data fusion. Without
preprocessing, the scales for each data set would have been dra-
matically different and this would have caused inappropriate and
Acetylsalicylic acid (ASA) was purchased from Alfa Aesar
unequal weighting in the models. Therefore, the FTIR data set and
(Ward Hill, MA). Acetaminophen (APAP) was purchased from
the PXRD data set were preprocessed using the standard normal
Ortho-McNeil Pharmaceuticals (Titusville, NJ). Ibuprofen (IBU) and
variate (SNV) function in the PLS Toolbox (Eigenvector Research,
caffeine (CAF) were purchased from Spectrum Chemical (Gardena,
Inc., Wenatchee, WA, USA). The SNV function standardizes the
row vectors to mean zero and unit variance. Additionally, the CO2
peak, including data from 2268 cm−1 to 2402 cm−1 was removed
2.2. Experimental design
from each FTIR spectrum and the FTIR data above 3377 cm−1 were
removed since they did not contain any useful information. After
Four active ingredients (APAP, ASA, CAF and IBU) were tested
removal of these data points, the FTIR spectra contained 1346 data
by a four-component simplex-centroid design (SCD). The four-
points. After preprocessing, the data were considered normalized,
component SCD was used to achieve better predictability with a
allowing the multivariate models to apply appropriate weightings
high accuracy of unknown fractions of subjected active ingredients
to each variable to yield the most descriptive models. For FPD, the
total, 21 combinations of subjected active ingredients were
normalized data for each sample was fused by concatenating its
tested by both FTIR and PXRD techniques (4 vertices for
FTIR row vector with its PXRD row vector, resulting in row vectors
4 pure components, 6 edge centers of the binary mixtures with
with 4240 data points.
R.V. Haware et al. / Journal of Pharmaceutical and Biomedical Analysis 56 (2011) 944–949
Fig. 1. Schematic flow of data processing in the PLS prediction of the fusion of principal component scores (FPCS) data set. Blocks in the diagram are not intended to represent
matrix size. Matrix sizes are represented as M rows × N columns = M samples × N variables.
In FPCS, it was the PCA score values that were fused. A PCA was
the 21 calibration samples is complex due to the large quantity
performed on each individual data set. A PCA was performed on
of overlapping data; however, it is instructive to view an overlay
the normalized FTIR spectra of the 21 calibration samples and the
plot of the fingerprint spectral region of the 4 vertices (i.e. pure
4 unknown samples (a total of 25 samples). The intention of this
components). that each of the pure components has at
procedure was to extract as much variation from these samples as
least one absorption peak with little overlap from the peaks of other
possible so the score values of the first 20 principal components
pure components. Vertical lines are included in indicate the
were saved. Next, a PCA was performed on the PXRD data set and
locations of these unique peaks. APAP has a peak at 1562.1 cm−1,
the score values for its first 20 principal components were saved.
CAF has a peak at 744.4 cm−1, IBU has a peak at 779.1 cm−1, and
The score values from each technique were concatenated into one
ASA has a peak at 1562.1 cm−1. This feasibility check shows that
fused matrix of 25 rows (samples) by 40 columns (score values).
there is sufficient variation in the FTIR absorbance spectra to enable
Finally, this matrix was separated into a calibration matrix (21 rows
multivariate quantitative analysis of these 4 components. A simi-
by 40 columns) and an unknown matrix (4 rows by 40 columns).
lar analysis was performed on the functional group region of the
Thus, the fused data set was condensed from the respectively large
FTIR spectra (2400–3450 cm−1). It was found that APAP contained
number of variables (4240) to a matrix containing only 40 variables.
a unique peak at 3223 cm−1 representing the N–H vibration of its
secondary amine, but the rest of peaks in the functional group
2.6. Multivariate analysis (MVA)
region were broader than those in the fingerprint region. There-
fore, most of the peaks from a single component in the functional
Principal component analysis (PCA) followed by partial least
square regressions (PLS-2) were performed on the individual FTIR
and PXRD data, as well as on the fused data from both FTIR and PXRD
analysis, to check the three dimensional spatial distribution of the
score values (Unscrambler® 10.0.1, CAMO AS, Norway). Optimized
PLS-2 models were used to predict the unknown concentrations of
the ingredients in the mixtures. Leave-one-out cross validation was
used to calculate the PLS-2 models best PLS-2 model for
the prediction of the concentrations of the ingredients was selected
on the basis of yielding the lowest root mean square of cross vali-
dation (RMSECV) values.
Finally, the ability of the optimized PLS models based on an
individual FTIR data, PXRD data and the fused data were tested by
subjecting the data of four unknown samples mixtures of varying
compositions of active ingredients. A schematic of the data pro-
cessing steps involved in the PLS prediction of the FPCS is shown in
3. Results and discussion
00 12 00 1100 1000 900
3.1. Analysis of calibration samples by FTIR and PXRD
Fig. 2. Fingerprint region of the FTIR spectra of APAP, CAF, IBU, and ASA. Vertical
The FTIR spectra of the 21 calibration samples were obtained,
lines show locations of peaks for single components with little overlap from other
as indicated in Section overlay plot of the FTIR spectra of
R.V. Haware et al. / Journal of Pharmaceutical and Biomedical Analysis 56 (2011) 944–949
Normalized Intensity
Fig. 4. The fused FTIR spectra and PXRD patterns. The first 1346 data points rep-
Fig. 3. Powder X-ray diffraction patterns of the 4 pure components: APAP, CAF, IBU,
resent the FTIR spectra and data points 1347–4240 represent the PXRD patterns.
and ASA. Vertical lines show locations of peaks for single components with little
SNV was applied separately to each data set prior to concatenation. The tallest ASA
overlap from other components. The ASA peak at 2 = 15.5◦ was cut off to provide
peak (18.5 normalized intensity units) was cut off to provide a better view of the
an enlarged view of the majority of peaks in the pattern.
remaining peaks.
group region shared overlap with peaks from at least one of the
set is compressed into 3 principal components (PCs). Second, the
other pure components.
pure component samples (labeled as 1-APAP, 2-CAF, 3-IBU, and 4-
A similar feasibility check was performed on the PXRD patterns
ASA) align themselves at the vertices of a trigonal pyramid. Third,
of the four pure components. the PXRD patterns for
each of the calibration samples aligns itself at the expected location
each of the pure components. Vertical lines are included in
within the three dimensional structure. For example, sample #8 is
to point out that there is at least one peak for each component
50% (2-CAF) and 50% (3-IBU); thus aligning itself halfway between
with little overlap from the peaks of other components. APAP has
samples 2 and 3 while not showing any orientation with samples 1
a peak at 2 = 24.2067◦, CAF has a peak at 2 = 11.6477◦, IBU has
and 4. Furthermore, the center-points (samples 19, 20, and 21) are
a peak at 2 = 18.565◦, and ASA has a peak at 2 = 7.6964◦. Again,
precisely overlapping one another and located at the center of the
this feasibility check shows there is sufficient variation in the PXRD
pattern to enable multivariate quantitative analysis of the four pure
shows the resulting three-dimensional PCA plots for the
FTIR data sets for the 21 calibrations samples. A similar trigonal
Since it was found that each technique could measure variation
pyramidal structure emerges, however, the error in the measure-
in each of the four components, the next step was to fuse the data.
ment is evident as the calibration samples do not align themselves
In FPD, the data sets were concatenated after preprocessing each
at the exact locations of the pyramid that would be expected. For
individual data set with SNV. The resulting overlay plots of the four
example, sample 7, which is 50% (1-APAP) and 50% (4-ASA), is found
pure components for the normalized and fused data vectors are
somewhat half way between samples 1 and 4, but it is now located
shown in Data points 1–1346 represented the FTIR spectra
off of the line connecting vertex points 1 and 4. shows the
and data points 1347–4240 represented the PXRD patterns. While
corresponding PCA plot for the PXRD patterns for the 21 calibration
there were more data points in the PXRD data, there was a similar
samples. Again, the same pattern emerges and it appears there is
degree of variation in each of the data sets due to preprocessing
less error in the PXRD data set than in the FTIR data set. Finally, Fig
with SNV. This is ensured because the SNV subtracts the mean of
5D shows the corresponding PCA plot for the FPD. Again, the same
each data set from each data vector, then divides each data vector
pattern emerges and from a qualitative point of view, it appears
by the standard deviation each data set. Thus, the FTIR spectra and
there is less error in the FPD set than in the FTIR data set, but
the PXRD patterns have been placed onto similar normalized scales
approximately the same amount of error as in the PXRD data set.
and the fused data is now ready for multivariate analysis.
shows that the FTIR, PXRD and fused data sets, respec-
tively, track the trends in the concentration variance in the samples
(as elucidated in The next step is to use PLS to determine
3.2. PCA patterns and trends
the extent to which each of the methods can quantitatively pre-
dict the concentrations of each of the components in each of the
The purpose of using PCA is usually to elucidate trends or classify
samples within data sets. The trends in the 21 calibration samples
were clear as these trends were deliberately introduced into the
four-component simplex-centroid experimental design. The ques-
3.3. PLS quantitative predictions for calibration samples A
tion is whether the analytical tools were sensitive to those trends
and whether the fused data would provide better sensitivity to the
PLS was performed on each of the data sets (FTIR, PXRD, and
trends. To examine these questions, a PCA was first performed on
fused data) to determine the accuracy of prediction for each of the
the y-data block (the concentration matrix) of the experimentally
components. an example of the PLS results for the
designed data set (i.e. the pure component percentages listed in
prediction of APAP. Similar trends in results were seen for CAF, IBU,
The resulting PCA plot is given in showing sev-
and ASA, although each of the plots is not included here.
eral interesting features. First, 100% of the variation in the data
shows the PLS prediction based on the FTIR data set for each of the
R.V. Haware et al. / Journal of Pharmaceutical and Biomedical Analysis 56 (2011) 944–949
Fig. 5. PCA of (A) the percentages of the pure components in the 21 calibrations samples, (B) the preprocessed FTIR spectra of the 21 calibration samples, (C) the preprocessed
PXRD patterns of the 21 calibration samples, and (D) the fusion of preprocessed data (FPD) set representing the 21 calibration samples. The percent variance captured by
each PC is shown in parenthesis along each axis.
21 calibration samples. shows the corresponding plot for the
FPCS. The RMSEC and RMSECV values included in
PXRD patterns. As can be seen from the decrease in the scatter in
that the PXRD prediction (is better than the FTIR prediction
the plot as well as the decrease in RMSEC and RMSECV values, the
(but the FPCS prediction (is better than both the
PLS model for the PXRD patterns did a better job of prediction than
FTIR and PXRD data sets when they are used alone. The RMSECV
the PLS model built on the FTIR data. A PLS model was also built on
values were calculated using the "leave one out" cross validation
the FPD set and the results were very similar to those obtained from
method. Each of the RMSEC and RMSECV values for each of the
the PXRD PLS model. However, using the FPCS approach, there was
four components is detailed in results indicate that a
an improvement in the accuracy of the prediction. shows
FPCS model based on the concatenation of PCA scores can be used
the corresponding plot for the PLS model that was applied to the
to improve prediction accuracy.
once ntratio n (%)
al APAP Co nce ntratio n (%)
AP Concentratio n (%)
Fig. 6. Representative predicted vs. measured models obtained by partial least square regression (PLS-2) of the (A) FTIR spectra, (B) PXRD patterns, and (C) fusion of principal
component scores (FPCS) data for the quantitative prediction of APAP.
R.V. Haware et al. / Journal of Pharmaceutical and Biomedical Analysis 56 (2011) 944–949
analysis, can improve the prediction outcome as compared with
Summary of partial least square regression (PLS-2) models (RMSEC, root means
the single instrument PLS prediction outcomes. Furthermore, it
square error of calibration; RMSECV, root mean square error of prediction; PCs,
was found that the FPCS PLS prediction outperformed the FPD PLS
Partial least square regressions
FTIR
Optimum no. of PCs used
The present work demonstrates the ability of data fusion to
combine the information in the FTIR and PXRD data for bet-
ter quantification and prediction of the amounts of APAP, CAF,
IBU and ASA from blended, powder mixtures. PCA of FTIR data,
Optimum no. of PCs used
PXRD data, and the FPD indicated that, with some error, each
of the data sets showed similar trends to the concentration
Fusion of principal component scores (FPCS)
variation intrinsic in the 21 calibration samples. The use of
Optimum no. of PCs used
FPCS was the key to improving the PLS prediction. A compar-
ison of the PLS regression analysis of the FTIR data, the PXRD
data, the FPD and the FPCS demonstrated that the FPCS pro-
duced the best prediction accuracies of unknown amounts of
active pharmaceutical ingredients. The improvement in predic-
Actual and predicted values of unknown samples of APAP, CAF, IBU and ASA by
tion accuracy of the FPCS method over the FPD method may be
partial least square regressions (PLS-2) method.
attributed to the noise removal and the data reduction associated
with extracting the principal component scores prior to build-
ing the PLS regression model. The implications for developing
distinctive signatures for unknown mixtures as in, e.g., natural
products, are an exciting direction under investigation in the UHH
[1] Guidance for Industry: Q8 Pharmaceutical Development, US Department
of Health and Human Services, Food and Drug Administration, Center for
Drug Evaluation and Research, Center for Biologics Evaluation and Research,
Rockville, 2006.
[2] A. Gupta, G.E. Peck, R.W. Miller, K.R. Morris, Real-time near-infrared monitoring
of content uniformity, moisture content, compact density, tensile strength, and
Young's modulus of roller compacted powder blends, J. Pharm. Sci. 94 (2005)
[3] S. Romero-Torres, J.D. Perez-Ramos, K.R. Morris, E.R. Grant, Raman spec-
troscopy for tablet coating thickness quantification and coating characteriza-
tion in the presence of strong fluorescent interference, J. Pharm. Biomed. Anal.
41 (2006) 811–819.
Fusion of principle component scores (FPCS)
[4] W. Cao, M.P. Mullarney, B.C. Hancock, S. Bates, K.R. Morris, Modeling of trans-
mitted X-ray intensity variation with sample thickness and solid fraction in
glycine compacts, J. Pharm. Sci. 92 (2003) 2345–2353.
[5] P.M. Ramos, I. Ruisanchez, K.S. Andrikopoulos, Micro-Raman and X-ray fluores-
cence spectroscopy data fusion for the classification of ochre pigments, Talanta
75 (2008) 926–936.
[6] V. Steinmetz, F. Sevila, V. Bellon-Maurel, A methodology for sensor fusion
design: application to fruit quality assessment, J. Agric. Eng. Res. 74 (1999)
3.4. PLS quantitative predictions for blind, unknown samples
[7] P. Boilot, E.L. Hines, M.A. Gongora, R.S. Folland, Electronic noses inter-
comparison, data fusion and sensor selection in discrimination of standard fruit
The PLS models built in Section PLS model of the
solutions, Sens. Actuators B 88 (2003) 80–88.
[8] S. Roussel, W. Bellon-Maurel, J.M. Roger, Authenticating white grape must
FTIR data, the PLS model of the PXRD data, and the PLS model
variety with classification models based on aroma sensors, FT-IR and UV spec-
of the FPCS) were applied to unknown samples. The actual and
trometry, J. Food Eng. 60 (2003) 407–419.
predicted values for each of the four components in each of the
[9] J. Esteban, A. Starr, R. Willetts, P. Hannah, P. Bryanston-Cross, A review of
data fusion models and architectures: towards engineering guidelines, Neural
four unknowns are given in The results indicate that the
Comput. Appl. 14 (2005) 273–281.
PXRD PLS prediction is more accurate than the FTIR PLS predic-
[10] J. Llinas, D.L. Hall, An introduction to multi-sensor data fusion, Proc. IEEE Int.
tion, but the FPCS PLS prediction is more accurate than either of
Symp. Circuit Syst. 6 (1998) 537–540.
[11] K. Esbensen, S. Schoenkopf, T. Midtgaard, D. Guyot, Multivariate Data Analysis
the single instrument PLS predictions. Again, the FPD model did
– In Practice, Camo ASA, Trondheim, Norway, 1994.
not improve the accuracy prediction over the single instrument
[12] H. Martens, M. Martens, Modified Jack-knife estimation of parameter uncer-
PLS predictions. Therefore, these results indicate that FPCS, com-
tainty in bilinear modelling by partial least squares regression (PLSR), Food
Qual. Pref. 11 (2000) 5–16.
bined with appropriate preprocessing and multivariate statistical
Source: http://www.bioinf.uni-freiburg.de/Publications/Haware_Wright_Morris-Data_fusio_Fouri-2011.pdf
Thermo Scientific iCAP 7000 Series ICP-OES The new Thermo Scientific™ iCAP™ 7000 Series ICP-OES provides the lowest cost multi-element analysis for measuring trace elements in a diverse sample range, combining advanced performance with high productivity and ease of use. The instrument provides your environmental, pharmaceutical, industrial or food safety facility with the lowest cost of analysis per sample, producing consistently reliable data, whilst ensuring compliance to global regulations and standards.
Management of acute and chronic migraine Gianluca Cand Jean Sc Purpose of reviewWe highlight the recent clinical trials for the management of acute and chronic migraine. Recent findingsIn women with menstrual migraine, triptans seem to be well tolerated irrespective of whether or not patientsare taking oestrogen-containing contraceptives or have comorbidities that indicate increased cardiovascularrisk. The new acute drug, telcagepant, a calcitonin gene-related peptide (CGRP) antagonist, is safe forlong-term use (up to 18 months) in migraine patients with stable coronary artery disease in whom the useof triptans is not advisable. From the pooled analysis of the two Phase III Research Evaluating MigraineProphylaxis Therapy studies of onabotulinumtoxinA (BOTOX) in chronic migraineurs, it clearly emerged thatefficacy increases overtime (up to 56 weeks) and paralleled self-perceived improvement in quality of life.Effectiveness was also observed in patients with severely disabling headaches, who met criteria for triptanabuse and were refractory to several prophylactic treatments. Finally, combination of preventivepharmacological agents with different action mechanisms may be the next frontier in therapeuticadvancements for treating migraine.